Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients.

Autor: Kyr M; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; International Clinical Research Centre, St. Anne's University Hospital in Brno, Brno, Czech Republic., Mudry P; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Polaskova K; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Dubska LZ; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Laboratory Medicine, University Hospital Brno, Brno, Czech Republic.; Department of Laboratory Methods, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Advanced Therapy and Immunotherapy Centre (CREATIC), Faculty of Medicine, Masaryk University, Brno, Czech Republic., Demlova R; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Laboratory Medicine, University Hospital Brno, Brno, Czech Republic.; Central European Advanced Therapy and Immunotherapy Centre (CREATIC), Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kubatova J; Central European Advanced Therapy and Immunotherapy Centre (CREATIC), Faculty of Medicine, Masaryk University, Brno, Czech Republic., Hlavackova E; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Advanced Therapy and Immunotherapy Centre (CREATIC), Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Clinical Immunology and Allergology, St. Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Pilatova KC; Department of Laboratory Medicine, University Hospital Brno, Brno, Czech Republic.; Central European Advanced Therapy and Immunotherapy Centre (CREATIC), Faculty of Medicine, Masaryk University, Brno, Czech Republic., Mazanek P; Department of Pediatric Hematology and Biochemistry, Children's University Hospital Brno, Brno, Czech Republic., Vejmelkova K; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; International Clinical Research Centre, St. Anne's University Hospital in Brno, Brno, Czech Republic., Dusek V; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Tinka P; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; International Clinical Research Centre, St. Anne's University Hospital in Brno, Brno, Czech Republic., Balaz M; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Merta T; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kuttnerova Z; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Turekova T; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Pavelka Z; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Pokorna P; Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Palova H; Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Mlnarikova M; Central European Advanced Therapy and Immunotherapy Centre (CREATIC), Faculty of Medicine, Masaryk University, Brno, Czech Republic., Jezova M; Department of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kellnerova R; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kozakova S; Department of Pharmacy, University Hospital Brno, Brno, Czech Republic., Slaby O; Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Valik D; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Laboratory Medicine, University Hospital Brno, Brno, Czech Republic.; Department of Laboratory Methods, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Advanced Therapy and Immunotherapy Centre (CREATIC), Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sterba J; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Oct 15; Vol. 155 (8), pp. 1443-1454. Date of Electronic Publication: 2024 Jul 03.